• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Evernorth acquires tech platform Bright.md to enhance MDLIVE offerings

Share:

October 17, 2023

Cigna’s health services subsidiary, Evernorth, has acquired Bright.md, an asynchronous platform, to enhance the virtual care offerings of its portfolio company, MDLIVE. Bright.md’s platform streamlines patient intake and virtual care connections, enabling patients to input symptoms and background information for clinicians to provide provisional diagnoses and treatment plans. MDLIVE, a 24/7 virtual care platform, plans to integrate asynchronous care, health coaching, and expand its services, aiming to improve patient access and reduce healthcare costs. This move aligns with Cigna’s commitment to expanding telehealth services for its enrollees.

Insurer Cigna’s health services subsidiary Evernorth announced it acquired asynchronous platform Bright.md, which it will use to enhance the virtual care offerings of its portfolio company MDLIVE.

Portland-based Bright.md offers an automated patient intake and virtual care connection platform to improve efficiency for hybrid care providers and patients.

Through Bright.md’s platform, patients enter their symptoms and background information that providers normally collect during an initial face-to-face encounter. Clinicians are then provided with a provisional diagnosis and treatment plan for review, which is automatically entered into the EHR.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

MDLIVE is a virtual care platform that offers 24/7 access to healthcare providers via phone or video. The company provides urgent care, primary care, mental health and dermatology services.

MDLIVE announced it will start offering asynchronous care through its virtual urgent care platform in 2024, with plans to expand the tool to its chronic disease management and wellness visits over time.

The company said it will also add health coaching in its virtual primary care service for patients with chronic conditions.

“We continually challenge ourselves to improve the health care experience, and by integrating these capabilities, we will significantly improve patient access to high-quality care, free up clinicians to spend more meaningful time with patients and reduce the total cost of care,” Dr. Eric Weil, chief medical officer at MDLIVE, said in a statement. “Ultimately, this will help patients get care faster and facilitate more meaningful patient-provider interactions that improve health.”

THE LARGER TREND

Evernorth acquired MDLIVE in 2021, and, shortly after, Cigna announced it would offer access to enrollees in employee-sponsored health plans access to telehealth services via MDLIVE. It also launched a virtual-first plan for select employers.

Source: Mobihealthnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • AI-Powered Emotion Analysis Technology to Help Diagnose Mental Health Conditions in Seniors in SingaporeAI-Powered Emotion Analysis Technology to Help Diagnose Mental Health Conditions in Seniors in Singapore
  • Rethinking Patient Access: 4 Key Actions for Health SystemsRethinking Patient Access: 4 Key Actions for Health Systems
  • Pediatric-Focused Mental Health Startup Brightline Scores $72M in Series B FundingPediatric-Focused Mental Health Startup Brightline Scores $72M in Series B Funding
  • ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Osiris Therapeutics, Inc.ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Osiris Therapeutics, Inc.
  • Human API nets $10 million in funding to advance machine learning toolsHuman API nets $10 million in funding to advance machine learning tools
  • Indian Health Tech Startup CureBay Scores $6M in Series A FundingIndian Health Tech Startup CureBay Scores $6M in Series A Funding
  • Orphazyme A/S Under In-Court-Restructuring to Sell Substantially all of Its Assets and Business Activities to KemPharm, Inc.Orphazyme A/S Under In-Court-Restructuring to Sell Substantially all of Its Assets and Business Activities to KemPharm, Inc.
  • Otsuka and Sunovion Ink Neuropsychiatric Medicine Deal Worth Nearly $1 BillionOtsuka and Sunovion Ink Neuropsychiatric Medicine Deal Worth Nearly $1 Billion

Trending This Week

  • Scotland’s Life Sciences Strategy Targets £25bn
  • Nectar Lifesciences Shares Surge on Buyback News
  • SUPRIYA Lifescience Strategic Growth Through Advanced Manufacturing
  • Investment Guide Buy Sell Hold Five Stocks
  • Supriya Lifescience Stock Analysis and Outlook
  • Eiko Lifesciences Financial Performance Analysis 2025

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications